Insecticides (India) enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,491	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
91.7	91.7	65.5	61.2	18.6
144	144	99.6	83.2	159
1,544	—	—	—	—
52.6	52.6	34.1	22.0	140
₹530.53	—	—	—	—

1,365	1,365	1,184	1,097	1,077
10.6%	10.6%	8.4%	7.6%	14.8%
0.09×	—	—	—	—

0.75×	—	—	—	—
7.35×	—	—	—	—
8.97×	—	—	—	—
273.00×	—	—	—	—
2,060	2,140	2,000	1,966	1,801
210	227	221	163	122
172	192	192	133	95.8
—	100	93.5	184	−10.6
5.7	5.7	56.2	135	−98.1
—	1.4	54.3	132	−101
—	94.6	37.3	49.0	87.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INSECTICID₹512.45

Insecticides (India) Limited

· Chemicals

₹ CrorePeersIPL MOL BHARATRAS PUNJABCHEM ASTEC GSPCROP DHARMAJ BHAGCHEMMcap ₹1,491 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,491.1
- Cash, Equiv & ST Investments	18.6	61.2	65.5	91.7	91.7
+ Total Debt	159.1	83.2	99.6	144.3	144.3
Enterprise Value	—	—	—	—	1,543.7
Net Debt (memo)	140.4	22.0	34.1	52.6	52.6
EV per Share	—	—	—	—	530.53

Total Capital	1,077.4	1,096.7	1,184.2	1,364.7	1,364.7
Total Debt/Total Capital	14.76	7.59	8.41	10.57	10.57
Total Debt/EV	—	—	—	—	0.09

EV/Sales	—	—	—	—	0.75
EV/EBITDA	—	—	—	—	7.35
EV/EBIT	—	—	—	—	8.97
EV/Free Cash Flow	—	—	—	—	273.00
Reference Items — Trailing FY Values
Sales	1,801.3	1,966.4	1,999.9	2,140.0	2,060.4
EBITDA	121.9	162.6	221.2	227.0	210.1
EBIT	95.8	133.3	192.1	191.6	172.2
Operating Cash Flow	-10.6	183.7	93.5	100.2	—
Free Cash Flow	-98.1	134.7	56.2	5.7	5.7
FCFF (free cash flow to the firm)	-101.3	132.2	54.3	1.4	—
Capital Expenditure	87.5	49.0	37.3	94.6	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.